TORINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 20.763
EU - Europa 1.908
AS - Asia 1.096
OC - Oceania 24
SA - Sud America 17
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 23.829
Nazione #
US - Stati Uniti d'America 20.719
IT - Italia 576
SG - Singapore 504
UA - Ucraina 302
CN - Cina 253
DE - Germania 244
IE - Irlanda 220
RU - Federazione Russa 144
GB - Regno Unito 93
FI - Finlandia 82
FR - Francia 75
KR - Corea 73
VN - Vietnam 60
ID - Indonesia 46
SE - Svezia 43
CA - Canada 38
JP - Giappone 36
TR - Turchia 30
NL - Olanda 25
BE - Belgio 24
CZ - Repubblica Ceca 23
AU - Australia 21
IN - India 21
TW - Taiwan 19
IR - Iran 15
HK - Hong Kong 13
AL - Albania 9
GR - Grecia 8
BR - Brasile 7
CH - Svizzera 7
RO - Romania 7
CL - Cile 6
EU - Europa 6
PH - Filippine 6
PL - Polonia 6
EG - Egitto 5
NO - Norvegia 5
TH - Thailandia 5
DK - Danimarca 4
AT - Austria 3
MX - Messico 3
MY - Malesia 3
PT - Portogallo 3
AR - Argentina 2
BD - Bangladesh 2
CR - Costa Rica 2
KG - Kirghizistan 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BW - Botswana 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
PG - Papua Nuova Guinea 1
Totale 23.829
Città #
Woodbridge 6.053
Houston 5.159
Wilmington 5.085
Fairfield 633
Chandler 604
Ann Arbor 454
Singapore 422
Ashburn 315
Seattle 266
Jacksonville 250
Rome 217
Dublin 209
Cambridge 208
Medford 155
Beijing 120
Dearborn 102
New York 99
Santa Clara 91
Lawrence 75
Redwood City 57
Moscow 44
Boardman 42
Jakarta 40
San Diego 40
Dong Ket 39
Milan 37
Menlo Park 30
London 27
Mülheim 27
Phoenix 25
Nanjing 22
Brno 21
Helsinki 21
Brussels 20
Sanayi 18
Escondido 16
Lachine 16
New Kensington 16
Norwalk 16
University Park 16
Munich 14
Taipei 13
Toronto 13
Falls Church 12
Mountain View 12
Guangzhou 11
Naples 11
Zhengzhou 11
Hefei 10
Florence 9
Shanghai 9
Engelhard 8
Kunming 8
Tokyo 8
Annapolis 7
Nanchang 7
Manila 6
Nürnberg 6
San Jose 6
Seoul 6
Baltimore 5
Bologna 5
Bungarribee 5
Council Bluffs 5
Creede 5
Los Angeles 5
Moniga del Garda 5
Pune 5
Redmond 5
San Giuliano Milanese 5
São Paulo 5
Verona 5
Athens 4
Giugliano in Campania 4
Hanoi 4
Istanbul 4
Jinan 4
Kraków 4
Lappeenranta 4
Melbourne 4
Montreal 4
Nuremberg 4
Palermo 4
Palo Alto 4
Rho 4
Shenyang 4
Sydney 4
The Dalles 4
Torino 4
Amsterdam 3
Bellinzona 3
Catania 3
Cedarhurst 3
Champaign 3
Chengdu 3
Chicago 3
Dresden 3
Gorizia 3
Groningen 3
Heidelberg 3
Totale 21.455
Nome #
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. 528
Prometheus: A Project for the Dissemination of Knowledge within the Oncology Network of Piedmont and Aosta Valley. 504
La mutualità nel caregiving: una revisione della letteratura 503
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES) 477
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 468
Focus on Fotemustine 444
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells 440
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. 432
A rare case of juvenile hypertension: Coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism 428
Thyroid dysfunction as an unintended side effect of anticancer drugs. 424
Circulating tumor cells in colorectal cancer patients 421
Medullary thyroid cancer: a promising model for targeted therapy. 418
Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis. 416
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 414
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 411
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 410
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). 408
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives. 405
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. 402
Endocrinological side-effects of immune checkpoint inhibitors 400
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 396
Mouse models of medullary thyroid cancer and developing new targeted therapies 394
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? 393
Thyroid Function Abnormalities in Patients Receiving Anticancer Agents. 393
Endocrine side effects induced by immune checkpoint inhibitors. 392
Targeted therapy of breast cancer. 391
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model 391
The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer. 386
Therapeutic agents that inhibit angiogenesis. 385
Endocrine side effects induced by immune checkpoint inhibitors. 383
"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging. 382
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy 381
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. 379
Skin acrometastases in squamous cell carcinoma of the tongue. 375
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 372
Genetic and molecular pathophysiology of medullary thyroid cancer. 369
Predicting ovarian activity in women affected by early breast cancer: Ameta-analysis-based nomogram 367
Therapy of breast cancer with molecular targeting agents. 365
AMBRA1 and SQSTM1 expression pattern in prostate cancer 362
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 361
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. 354
Tailored therapy of colorectal cancer: results, challenges and future directions. 353
Clinical utility of lanreotide autogel® in gastroenteropancreatic neuroendocrine tumors 353
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. 347
Is tailored therapy feasible in oncology? 343
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES). 343
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? 338
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. 335
Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. 332
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. 330
Combination of antiangiogenic therapy with other anticancer treatment. 328
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 323
Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy. 322
Barriers in the management of cancerrelated pain and strategies to overcome them: findings of a qualitative research involving physicians and nurses in Italy 319
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 318
Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. 306
Molecular targeted therapy of medullary thyroid carcinoma 294
Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer 174
Gut microbiota and cancer: From pathogenesis to therapy 174
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art 153
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 123
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms 107
Development and content validity of the self-care of oral anticancer agents index 98
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? 87
Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial? 84
null 75
Describing self-care behaviours in cancer patients taking oral anticancer agents 73
Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study 59
A systematic review of self-care behaviours among patients with cancer who take oral anticancer agents 59
La Terza Missione dell'Università: formazione e salute 58
Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review 57
Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review 55
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review 50
Apoptosis as a Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer 42
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention 38
Self-care behaviours in older adults treated with oral anticancer agents: A qualitative descriptive study 34
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 34
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 32
Metabolic reprogramming of castration-resistant prostate cancer cells as a response to chemotherapy 32
Caregivers’ contribution to self-care for patients treated with oral anticancer agents: A qualitative descriptive study 31
Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI) 30
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 30
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 30
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 30
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition 26
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 26
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 24
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 22
Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature 18
Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis 18
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy 15
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 15
Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task 14
CN29 Short term effects of self-care behaviours on quality of life for patients on oral anticancer agents 10
Core Outcomes of Self-Care Behaviours in Patients with Breast Cancer Treated with Oral Anticancer Agents: A Systematic Review 7
Urine LOX-1 and volatilome as promising tools towards the early detection of renal cancer 4
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 1
Totale 24.057
Categoria #
all - tutte 52.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.409 0 0 0 0 0 647 493 492 490 480 422 385
2020/20213.600 376 435 344 455 344 406 428 321 81 165 148 97
2021/2022939 47 76 41 50 36 72 47 44 53 110 69 294
2022/20231.461 143 156 131 163 107 271 83 94 117 24 126 46
2023/2024626 86 34 32 27 48 108 37 32 22 17 16 167
2024/20251.082 89 483 201 136 77 96 0 0 0 0 0 0
Totale 24.057